Pharmaceuticals

How Evogene is changing the future for the pharma and agriculture markets

AI-driven small molecule discovery, which underlies most drugs on the market, is a challenge being tackled through science and technology

Automated pharmaceutical conveyor line, robotic arms handling medical vials
 Illustrative photo shows various medicine pills in their original packaging

Taking too many medications may harm older adults, study warns

Noam Zilbershtain, senior vice president and general manager, HP Indigo; Adi Soffer Teeni, CEO of Meta Israel, vice president and member of the EMEA leadership team; and Karin Mayer Rubinstein, CEO and president of IATI.

IATI CEOs Forum meets in Kiryat Gat to discuss multinational industry resilience

Mrs. Glassman enjoys a cup of coffee at one of the Jerusalem cafés she frequented

A Passover tribute: Kindness from a Jerusalem neighborhood pharmacy


Israel’s healthcare workforce lags behind OECD averages despite growth in doctors and nurses

Despite an increase in medical professionals, Israel’s healthcare workforce remains below the OECD average, highlighting ongoing challenges.

Doctor holds a stethoscope in front of a hospital background (illustrative)

Teva share price struggles to recover following $6 billion market loss

The financial results were actually positive, at the higher end of analysts' forecasts, but profit guidance for 2025 disappointed the market.

 Pills on health form

Israel on the pharma frontier: How AION Labs is incubating the next drug development breakthrough

The Inside Israeli Innovation Podcast: Season 2, Episode 43.

 AION Labs CTO Dr. Yair Benita

Immunai and Teva partner to innovate new cancer, immunology therapies

The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.

 An Israeli flag flutters near the logo of Teva Tech which is part of Teva Pharmaceutical Industries in Neot Hovav, southern Israel December 14, 2017.

Israeli mapping company ImmunAI partners with AstraZeneca

The Israeli-American unicorn company ImmunAI has signed a multi-year cooperation agreement with the pharmaceutical giant AstraZeneca for the advanced optimization of clinical trials.

 Signing a lasting power of attorney

Immunai, AstraZeneca collaborate to optimize cancer clinical trials

Under the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform certain oncology clinical trials.

Cancer (Illustrative)

Kahun’s pharma-focused AI agent: Bridging medical knowledge and patient care

Kahun’s new AI Agent is revolutionizing healthcare by providing real-time, patient-specific medical insights, helping doctors stay updated on pharmaceutical developments while improving patient care.

  AI (Artificial Intelligence) letters are placed on computer motherboard in this illustration taken, June 23, 2023

Mounjaro: the next big thing in weight loss, now heading to Israel

Mounjaro is a new-generation injection that mimics two hormones in the body: GLP-1 and GIP. These hormones influence several processes in the body, including blood sugar regulation and satiety.

 Weight loss injections: Reducing sugar and increasing satiety.

Israel set to start selling pharmaceuticals outside of pharmacies

The Knesset Health Committee approved ordinances for the Pharmacists’ Regulations that would expand the list of active ingredients in drugs to be sold without a prescription and outside pharmacies

 Pills on health form

We must change the prejudices of mainstream medicine against lifestyle intervention - opinion

Lifestyle medicine prevents and reverses many chronic conditions and even auto-immune ones.

 DEAN ORNISH, president and founder of the Preventive Medicine Research Institute and a clinical professor of medicine at University of California, San Francisco, speaks during the Milken Institute Global Conference in Beverly Hills, in 2017.